FDA approves 1st nonreplicating smallpox, monkeypox vaccine

The FDA has approved Jynneos, a smallpox and monkeypox live and nonreplicating vaccine. 

It is the only vaccine approved by the FDA for monkeypox and the first live, non-replicating vaccine to prevent both diseases. 

Jynneos, approved for adults, will be available to those determined to be at high risk of acquiring smallpox or monkeypox.

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars